PD-1+CD8+T cells as immunological biomarkers for the safe discontinuation of anti-viral therapy in chronic hepatitis B

被引：2

作者：

Le Bert, N. ^{[1
]}

Rivino, L. ^{[2
]}

Gill, U. S. ^{[3
]}

Cheng, Y. ^{[4
]}

Kunasegaran, K. ^{[2
]}

Tan, D. Z. ^{[1
]}

Becht, E. ^{[4
]}

Hansi, N. K. ^{[3
]}

Foster, G. R. ^{[3
]}

Newell, E. W. ^{[4
]}

Kennedy, P. T. F. ^{[3
]}

Bertoletti, A. ^{[1
,2
,4
]}

机构：

[1] ASTAR, Singapore Inst Clin Sci, Infect & Immun Program, Singapore, Singapore

[2] Duke NUS Med Sch, Emerging Infect Dis Program, Singapore, Singapore

[3] QMUL, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunobiol,Hepatol, London, England

[4] ASTAR, Singapore Immunol Network, Singapore, Singapore

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(17)31847-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-152

引用

页码：S687 / S687

页数：1

共 50 条

[21] Circulating memory PD-1+CD8+ T cells and PD-1+CD8+T/PD-1+CD4+T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
Jiang Liu
Degan Liu
Guangyin Hu
Jingjing Wang
Dadong Chen
Chuanjun Song
Yin Cai
Chentong Zhai
Wenjing Xu
Cancer Cell International, 23
[22] A novel subset of anti-viral T cells: the CD161dim CD8+ population
Fergusson, J. R.
Ussher, J. U.
Newell, E. W.
Klenerman, P.
IMMUNOLOGY, 2012, 137 : 633 - 633
[23] Contribution of Herpesvirus Specific CD8 T Cells to Anti-Viral T Cell Response in Humans
Sandalova, Elena
Laccabue, Diletta
Boni, Carolina
Tan, Anthony T.
Fink, Katja
Ooi, Eng Eong
Chua, Robert
Schreve, Bahar Shafaeddin
Ferrari, Carlo
Bertoletti, Antonio
PLOS PATHOGENS, 2010, 6 (08) : 47 - 48
[24] Circulating memory PD-1+CD8+ T cells and PD-1+CD8+T/PD-1+CD4+T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
Liu, Jiang
Liu, Degan
Hu, Guangyin
Wang, Jingjing
Chen, Dadong
Song, Chuanjun
Cai, Yin
Zhai, Chentong
Xu, Wenjing
CANCER CELL INTERNATIONAL, 2023, 23 (01)
[25] Letter: programmed death-1-a predictor for anti-viral treatment in chronic hepatitis B
Vyas, Ashish Kumar
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (04) : 748 - 748
[26] Effects of HBV gene variations on disease development and anti-viral therapy in chronic hepatitis B patients
Gong, Zuo-Jiong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A14 - A14
[27] Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen
Londono, M. -C.
Lens, S.
Marino, Z.
Bonacci, M.
Ariza, X.
Broquetas, T.
Pla, A.
Bartres, C.
Adriani, M. V.
Rodriguez-Tajes, S.
Costa, J.
Carrion, J. A.
Perez-del-Pulgar, S.
Forns, X.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) : 1156 - 1161
[28] Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B
Kranidioti, Hariklia
Manolakopoulos, Spilios
Kontos, George
Breen, Michael S.
Kourikou, Anastasia
Deutsch, Melanie
Quesada-Del-Bosque, Maria Ester
Martinez-Nunez, Rocio T.
Naiyer, Mohammed M.
Woelk, Christopher H.
Sanchez-Elsner, Tilman
Hadziyannis, Emilia
Papatheodoridis, George
Khakoo, Salim, I
JOURNAL OF VIRAL HEPATITIS, 2019, 26 (06) : 697 - 709
[29] Metabolic programming of exhausted CD8 T cells in chronic viral hepatitis
Winkler, Frances
Hensel, Nina
Villa, Matteo
Pearce, Erika
Martin, Bianca
Wohlleber, Dirk
Thimme, Robert
Hofmann, Maike
Bengsch, Bertram
JOURNAL OF HEPATOLOGY, 2020, 73 : S84 - S84
[30] TCRγδ+CD4-CD8- T Cells Suppress the CD8+ T-Cell Response to Hepatitis B Virus Peptides, and Are Associated with Viral Control in Chronic Hepatitis B
Lai, Qintao
Ma, Shiwu
Ge, Jun
Huang, Zuxiong
Huang, Xuan
Jiang, Xiaotao
Li, Yongyin
Zhang, Mingxia
Zhang, Xiaoyong
Sun, Jian
Abbott, William G. H.
Hou, Jinlin
PLOS ONE, 2014, 9 (02):

← 1 2 3 4 5 →